About
OncoPrecision develops precision oncology therapeutics using patient-derived tumor biology and AI-driven target validation to design antibody-drug conjugates and bispecific antibodies targeting resistant blood cancers and solid tumors.
Explore OncoPrecision's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.